JanOne Inc. 티커 JAN 레딧 정보

Possible Squeeze - JanOne (JAN) is Trending as Its Lead Product for Pain Advances in Clinical Trials JanOne (JAN) is Trending as Its Lead Product for Pain Advances in Clinical Trials Good day everyone, We are initiating coverage on JanOne (NASDAQ: JAN) today. This one seems to be just starting to trend as 12% of the tiny 2.38M share float is currently sold short. This doesn't make a lot of sense to us as Jan is advancing clinical trials and has non-dilutive cash on hand from the sale of their legacy business. Current price $8.50 per share Outstanding shares (est.) 2.82M Float (est.) 2.38M..........

원문링크 : JanOne Inc. 티커 JAN 레딧 정보